Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

439 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology Group.
Yoon HH, Catalano P, Gibson MK, Skaar TC, Philips S, Montgomery EA, Hafez MJ, Powell M, Liu G, Forastiere AA, Benson AB, Kleinberg LR, Murphy KM. Yoon HH, et al. Among authors: benson ab. Cancer Chemother Pharmacol. 2011 Oct;68(4):863-70. doi: 10.1007/s00280-011-1556-5. Epub 2011 Feb 1. Cancer Chemother Pharmacol. 2011. PMID: 21286719 Free PMC article. Clinical Trial.
Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study.
Martenson JA, Lipsitz SR, Wagner H Jr, Kaplan EH, Otteman LA, Schuchter LM, Mansour EG, Talamonti MS, Benson AB 3rd. Martenson JA, et al. Among authors: benson ab 3rd. Int J Radiat Oncol Biol Phys. 1996 Jul 1;35(4):745-9. doi: 10.1016/0360-3016(96)00146-0. Int J Radiat Oncol Biol Phys. 1996. PMID: 8690640 Clinical Trial.
Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity.
Talamonti MS, Catalano PJ, Vaughn DJ, Whittington R, Beauchamp RD, Berlin J, Benson AB 3rd. Talamonti MS, et al. Among authors: benson ab 3rd. J Clin Oncol. 2000 Oct 1;18(19):3384-9. doi: 10.1200/JCO.2000.18.19.3384. J Clin Oncol. 2000. PMID: 11013279 Clinical Trial.
Randomized phase II trial of either fluorouracil, parenteral hydroxyurea, interferon-alpha-2a, and filgrastim or doxorubicin/docetaxel in patients with advanced gastric cancer with quality-of-life assessment: eastern cooperative oncology group study E6296.
Wadler S, Brain C, Catalano P, Einzig AI, Cella D, Benson AB 3rd. Wadler S, et al. Among authors: benson ab 3rd. Cancer J. 2002 May-Jun;8(3):282-6. doi: 10.1097/00130404-200205000-00013. Cancer J. 2002. PMID: 12074329 Clinical Trial.
Pilot study of gemcitabine (10 mg/m(2) per min) and cisplatin.
Poplin E, Benson A 3rd, Musanti R, Rubin E, Mulcahy M. Poplin E, et al. Cancer Chemother Pharmacol. 2002 Jul;50(1):80-3. doi: 10.1007/s00280-002-0461-3. Epub 2002 May 9. Cancer Chemother Pharmacol. 2002. PMID: 12111116 Clinical Trial.
A rose, is a rose, is a rose...or not.
Benson AB 3rd, Catalano PJ. Benson AB 3rd, et al. J Clin Oncol. 2004 May 15;22(10):1773-5. doi: 10.1200/JCO.2004.02.946. Epub 2004 Apr 5. J Clin Oncol. 2004. PMID: 15067029 No abstract available.
439 results